Bringing the fundamentals into focus…
Back to LivaNova PLC
How LivaNova PLC stacks up
LIVN · against 247 other Healthcare companies of similar size
Valuation
66/ 100
Above the middle of the pack.
Ranked #82 of 248 · scores higher than 65% of peers
Bars: peers in each 10-point band of the valuation score36 peers with a valuation score of 60–69, including LIVN · Click a bar to see the companies
Why valuation scores 66?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings yield, free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
- more operating profit (EBITDA) for the company's total value: stronger than 61% of peers. EBITDA yield: 6.1% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 69% of peers. Free cash flow yield: 3.4% vs peer median 0.0%
- higher earnings for the price paid: stronger than 73% of peers. Earnings yield: 4.3% vs peer median 1.5%
Metric by metric
Position: dot = LIVN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LIVN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 244 reported | 4.2% | 2.4% | 72% | 30% | |
| EBITDA yieldHigher is better · 242 reported | 6.1% | 4.9% | 61% | 50% | |
| Free cash flow yieldHigher is better · 135 reported | 3.4% | 0.8% | 66% | 20% | |
| Book yieldHigher is better · 244 reported | 30.1% | 27.0% | 56% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around LIVN| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 4 | 21.1B HKD (≈$2.7B) | 98 | 67 | |
| 4 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 79 | 74.2B SEK (≈$7.4B) | 67 | 55 | |
| 82 | 22.8B CNY (≈$3.2B) | 66 | 60 | |
| 82 | 5.1B USD | 66 | 54 | |
| 82 | 217.6B INR (≈$2.6B) | 66 | 67 | |
| 82 | 4.4B USD | 66 | 66 | |
| 82 | 3.2B USD | 66 | 65 | |
| 82 | 4.0B USD | 66 | 56 | |
| 88 | 23.0B CNY (≈$3.2B) | 65 | 64 | |
| 88 | 26.9B CNY (≈$3.8B) | 65 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score